Simplify Logo

Full-Time

Director – Leadership and Culture Learning Partner

Confirmed live in the last 24 hours

Moderna

Moderna

5,001-10,000 employees

Develops mRNA-based medicines for health

Healthcare
Biotechnology

Senior, Expert

Cambridge, MA, USA

70/30 work model requires 70% in-office presence.

Category
Human Resources
People & HR
Required Skills
Management
Requirements
  • Bachelor’s Degree or equivalent combination of education and experience
  • Minimum 10+ years of relevant experience
  • Proven track record of designing and implementing successful leadership development programs in a fast-paced, innovative environment.
  • Strong strategic planning and execution skills, with the ability to translate business needs into effective learning solutions.
  • Excellent collaboration and partnership skills
  • Strong project management, analytical, and evaluation skills.
  • Practical knowledge of learning operations, including portfolio execution, vendor management, learning technologies, and learning evaluation
  • Learning facilitation skills
Responsibilities
  • Develop and execute a comprehensive learning strategy for leadership, management, and organizational culture development that drives peak performance in alignment with Moderna’s goals and the People Platform’s vision of leadership excellence. Your learning portfolio will include everything from onboarding to senior executive development.
  • Develop, and continuously improve learning programs, utilizing the latest in learning science and technology to maximize effectiveness and engagement.
  • On occasion, facilitate or teach learning programs in partnership with internal and external leaders and SMEs
  • Act as a strategic partner to the People Platform team, ensuring that learning programs support the development of desired leadership competencies and management practices. Advise Functional Learning Business Partners on adapting programs for their functions
  • Integrate leadership and management learning programs within the broader talent management strategy to support succession planning, high-potential development, and organizational capability building.
  • Establish metrics and evaluation processes to assess the effectiveness of leadership and management learning, making data-driven decisions to enhance program impact.
  • Stay abreast of trends, research, and innovations in leadership and management development, applying best practices and exploring new methodologies to keep Moderna at the forefront of leadership excellence.
  • Manage relationships with external vendors and consultants to support program delivery, ensuring high-quality content and delivery standards. Delegate certain learning delivery tasks—such as enrollment planning and event management—to our small internal execution team while retaining accountability for results.

Moderna focuses on developing medicines using messenger RNA (mRNA), which is a molecule that provides instructions for cells to produce proteins essential for various biological functions. Their approach involves creating a new class of medicines that leverage mRNA to potentially enhance the discovery, development, and manufacturing of drugs. Unlike traditional methods, which often rely on proteins or other biological materials, Moderna's use of mRNA allows for a more versatile and efficient way to create treatments. The company's goal is to improve patient outcomes by harnessing the power of mRNA to address a wide range of health issues.

Company Stage

Grant

Total Funding

$5.9B

Headquarters

Cambridge, Massachusetts

Founded

N/A

Growth & Insights
Headcount

6 month growth

3%

1 year growth

8%

2 year growth

55%
Simplify Jobs

Simplify's Take

What believers are saying

  • Moderna's expansion into combination vaccines and autoimmune therapies showcases its potential for diversified revenue streams and market leadership.
  • The company's continuous innovation and FDA approvals for updated COVID-19 vaccines highlight its resilience and adaptability in a rapidly changing market.
  • Moderna's educational initiatives, like the free mRNA course, position it as a thought leader and advocate for mRNA technology.

What critics are saying

  • The collapse in demand for COVID-19 vaccines could significantly impact Moderna's revenue and growth prospects.
  • Ongoing class action lawsuits alleging securities fraud could damage Moderna's reputation and financial stability.

What makes Moderna unique

  • Moderna is pioneering the use of mRNA technology to create a new class of medicines, setting it apart from traditional pharmaceutical companies.
  • The company's focus on mRNA as the 'software of life' allows for rapid development and manufacturing of vaccines and therapies, unlike conventional methods.
  • Moderna's ability to secure regulatory approvals for mRNA vaccines beyond COVID-19, such as for RSV, demonstrates its leadership in mRNA technology.